-
Martin Shkreli (/ˈʃkrɛli/; born
March 17, 1983) is an
American investor and businessman.
Shkreli is the co-founder of the
hedge funds Elea Capital, MSMB...
- 42°20′N 19°38′E / 42.333°N 19.633°E / 42.333; 19.633
Shkreli is a
historical Albanian tribe and
region in the Malësia
Madhe region of
northern Albania...
-
Shkreli may
refer to:
Shkreli (region),
region in the Malësia
region of
Northern Albania Shkreli (tribe),
Albanian tribe Azem
Shkreli (1938–1997), Albanian...
-
winning bidder was
Martin Shkreli, the CEO of
Turing Pharmaceuticals, who paid a
reported $2 million. In
March 2018,
following Shkreli's conviction for securities...
- honors.
Shkreli is
Albanian ethnic origin, more
precisely of the
Shkreli subgroup of
Albanians who are a
minority in
coastal Montenegro.
Shkreli began his...
- Azem
Shkreli (Albanian pronunciation: [a'ʒɛm 'ʃkɾɛli]; Serbo-Croatian: Азем Шкрељи, Azem Škrelji; 10
February 1938 – 27 May 1997) was a
Yugoslavian writer...
-
manager Martin Shkreli and his
controversial monetary inflation of toxoplasmosis-related pharmaceuticals, it was
revealed that
Shkreli was a
silent investor...
-
years in prison. In
early 2016,
Martin Shkreli retained Brafman to
defend him. In a 2017 jury trial,
Shkreli was
found guilty on two
counts of securities...
-
price dropped around 10%
after the
price increase of the drug. CEO
Martin Shkreli faced immense criticism for his actions. The
company was
previously named...
- program.
Presentations from Retrophin, a
company formerly headed by
Martin Shkreli, CEO of Turing, from
which Turing acquired the
rights to Daraprim, suggested...
